FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003642007> ?p ?o ?g. }

• W3003642007 endingPage "672" @default.
• W3003642007 startingPage "669" @default.
• W3003642007 abstract "Natural fecundity of women decreases gradually and more rapidly after age 37 years. This decrease is accompanied by rising aneuploidy rates of pregnancies and can also be observed in products of conception of spontaneous abortions [1]. These observations lead to the hypothesis that transferring only euploid embryos in association with in vitro fertilization (IVF) might decrease miscarriages and increase live birth rates (LBRs), attesting-procedure now called preimplantation genetic testing (of embryos) for aneuploidy (PGT-A), until recently generally referred to as preimplantation genetic screening (PGS).Verlinsky and Kuliev further proposed that the removal of all aneuploid embryos prior to transfer would improve implantation rates and live birth rates and suggested that the diagnosis be made via biopsy of both polar bodies [2]. Polar body biopsy, however, proved technically too difficult for general IVF practice and would have revealed only meiotic aneuploidies. The procedure was, therefore, initially performed biopsying 1–2 blastomeres of day-3 cleavage-stage embryos, often given the acronym PGS 1.0.This form of embryo testing has, since, been replaced by PGS 2.0, with the embryo biopsy being moved from day-3 cleavage stage to trophectoderm biopsy of blastocyst-stage embryos on days 5–6 after fertilization. In July 2016, another major change in PGT-A was announced, for the first time introducing the concept pf “mosaic” embryos (also called PGS 3.) (Preimplantation Genetic Diagnosis Society (PGDIS) position statement on chromosome mosaicism and preimplantation aneuploidy testing at the blastocyst stage, Chicago, IL; July 19, 2016 http://pgdis.org/docs/newsletter_071816.html).After almost two decades of PGS 1.0 through PGS 3.0, the procedure has, however, still been unable to demonstrate the promised improvements in live births and anticipated declines in miscarriage rates [3–5]. Several studies, even summarized in a meta-analysis [6], have claimed improved clinical IVF outcomes following PGT-A. They, however, reported IVF outcomes with reference point embryo transfer rather than cycle start (intent-to-treat) and, therefore, by excluding poorer prognosis patients, were severely biased [7].The STAR studyThis is why the recently published STAR study [8] attracted special attention: It avoided at least some patient selection biases of earlier fresh-cycle studies by being prospectively randomized and reporting on IVF outcomes from transfers of only single frozen-thawed embryos at blastocyst stage. That qualifying patients required having at least two frozen embryos from a prior fresh cycle, however, still demonstrates a favorable patient selection bias. Importantly, however, the study at least analyzed outcomes for study and control groups with reference point initial first cycle start [7].In doing so, the study convincingly revealed no improvements in live birth rates and no reduction in miscarriage rates when cycle outcomes were compared in singe-embryo transfers at blastocyst stage between women, randomized to either PGT-A or only morphological assessments of a single embryo prior to transfers [8].For no declared reason, the authors then, however, performed a post hoc sub-group analysis based on age and reported, between ages 35 and 40 years, that PGT-A, still, offered significant increases in ongoing pregnancy rate (OPR). In the discussion of their manuscript, they emphasized this finding as “continuous evidence” for the clinical utility of PGT-A in at least that age group. Again, in contrast to the overall study that had been performed with reference point cycle start (intent-to-treat), their post hoc analysis was performed with reference embryo transfer and, therefore, statistically suspect.Because results of the STAR study are already impacting IVF practice worldwide, we here offer a statistically corrected analysis of the STAR study, reaffirming the study’s overall findings by refuting the results of the post hoc analysis and its interpretation by the authors, claimed benefits for PGT-A utilization for all age groups." @default.
• W3003642007 created "2020-02-07" @default.
• W3003642007 creator A5085797038 @default.
• W3003642007 creator A5088655691 @default.
• W3003642007 date "2020-02-02" @default.
• W3003642007 modified "2023-10-02" @default.
• W3003642007 title "Preimplantation genetic testing for aneuploidy (PGT-A)—finally revealed" @default.
• W3003642007 cites W1487359649 @default.
• W3003642007 cites W1628392279 @default.
• W3003642007 cites W2131300747 @default.
• W3003642007 cites W2147121501 @default.
• W3003642007 cites W2254703373 @default.
• W3003642007 cites W2344680589 @default.
• W3003642007 cites W2465680941 @default.
• W3003642007 cites W2520728487 @default.
• W3003642007 cites W2606037759 @default.
• W3003642007 cites W2973453946 @default.
• W3003642007 cites W4235037787 @default.
• W3003642007 doi "https://doi.org/10.1007/s10815-020-01705-w" @default.
• W3003642007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7125263" @default.
• W3003642007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32008181" @default.
• W3003642007 hasPublicationYear "2020" @default.
• W3003642007 type Work @default.
• W3003642007 sameAs 3003642007 @default.
• W3003642007 citedByCount "20" @default.
• W3003642007 countsByYear W30036420072020 @default.
• W3003642007 countsByYear W30036420072021 @default.
• W3003642007 countsByYear W30036420072022 @default.
• W3003642007 countsByYear W30036420072023 @default.
• W3003642007 crossrefType "journal-article" @default.
• W3003642007 hasAuthorship W3003642007A5085797038 @default.
• W3003642007 hasAuthorship W3003642007A5088655691 @default.
• W3003642007 hasBestOaLocation W30036420072 @default.
• W3003642007 hasConcept C104317684 @default.
• W3003642007 hasConcept C2776210078 @default.
• W3003642007 hasConcept C2779234561 @default.
• W3003642007 hasConcept C2779672484 @default.
• W3003642007 hasConcept C2780673598 @default.
• W3003642007 hasConcept C29456083 @default.
• W3003642007 hasConcept C30481170 @default.
• W3003642007 hasConcept C47042493 @default.
• W3003642007 hasConcept C54355233 @default.
• W3003642007 hasConcept C71924100 @default.
• W3003642007 hasConcept C86803240 @default.
• W3003642007 hasConceptScore W3003642007C104317684 @default.
• W3003642007 hasConceptScore W3003642007C2776210078 @default.
• W3003642007 hasConceptScore W3003642007C2779234561 @default.
• W3003642007 hasConceptScore W3003642007C2779672484 @default.
• W3003642007 hasConceptScore W3003642007C2780673598 @default.
• W3003642007 hasConceptScore W3003642007C29456083 @default.
• W3003642007 hasConceptScore W3003642007C30481170 @default.
• W3003642007 hasConceptScore W3003642007C47042493 @default.
• W3003642007 hasConceptScore W3003642007C54355233 @default.
• W3003642007 hasConceptScore W3003642007C71924100 @default.
• W3003642007 hasConceptScore W3003642007C86803240 @default.
• W3003642007 hasIssue "3" @default.
• W3003642007 hasLocation W30036420071 @default.
• W3003642007 hasLocation W30036420072 @default.
• W3003642007 hasOpenAccess W3003642007 @default.
• W3003642007 hasPrimaryLocation W30036420071 @default.
• W3003642007 hasRelatedWork W2026610247 @default.
• W3003642007 hasRelatedWork W2889376259 @default.
• W3003642007 hasRelatedWork W2890967989 @default.
• W3003642007 hasRelatedWork W2970893456 @default.
• W3003642007 hasRelatedWork W3003642007 @default.
• W3003642007 hasRelatedWork W3216697069 @default.
• W3003642007 hasRelatedWork W4300688554 @default.
• W3003642007 hasRelatedWork W4312095075 @default.
• W3003642007 hasRelatedWork W4378761560 @default.
• W3003642007 hasRelatedWork W4385380242 @default.
• W3003642007 hasVolume "37" @default.
• W3003642007 isParatext "false" @default.
• W3003642007 isRetracted "false" @default.
• W3003642007 magId "3003642007" @default.
• W3003642007 workType "article" @default.